Patent ID: 8278295
Filing Date: 2012-10-02
Classification: A61K,A61P,C07D

Abstract:
1. A compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: R (i) hydrogen, (ii) (C (iii) (C (iv) (C (v) (C (vi) (C (vii) (C (viii) 4 to 10 member heterocycloalkyl, optionally substituted with one to three substituents, the substituents being independently selected from the group consisting of (C (ix) aryl, optionally substituted with one to three substituents, the substituents being independently selected from the group consisting of (C (x) heteroaryl, optionally substituted with one to three substituents, the substituents being independently selected from the group consisting of (C R R n is 1 or 2; A is —CR R (i) hydrogen, (ii) (C (iii) (C (iv) 4 to 10 member heterocycloalkyl, (v) aryl, optionally substituted with one to three substituents, the substituents being independently selected from the group consisting of (C (vi) heteroaryl, optionally substituted with one to three substituents, the substituents being independently selected from the group consisting of (C (vii) LR R R R